Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Strom

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Drug Therapeutics|January 1, 1982
Post-marketing drug surveillance: an idea whose time has comeB L Strom
Annals of Internal Medicine|August 1, 1990
Pharmacoepidemiology: current status, prospects, and problemsB L Strom, P Tugwell
JAMA|April 20, 2001
Statins and fracture riskS Hennessy, B L Strom
Annals of Internal Medicine|February 26, 2000
Nonsedating antihistamines should be preferred over sedating antihistamines in patients who driveS Hennessy, B L Strom
Journal of Clinical Pharmacology|June 1, 1988
The gastrointestinal side effects of the nonsteroidal anti-inflammatory drugsJ L Carson, B L Strom
Journal of Chronic Diseases|January 1, 1986
Evaluating and monitoring the safety and efficacy of drug therapy and surgeryP D Stolley, B L Strom
Medical Toxicology|July 1, 1986
Techniques of postmarketing surveillance. An overviewJ L Carson, B L Strom
Clinical Pharmacology and Therapeutics|August 1, 1993
A systematic integrated approach to improvement of drug prescribing in an acute care hospital: a potential model for applied hospital pharmacoepidemiologyB L Strom, G A Gibson
American Journal of Respiratory and Critical Care Medicine|February 1, 1995
Inhaled beta-adrenergic receptor agonists in asthma: more harm than good?T E Barrett, B L Strom
JAMA|November 30, 1979
Can postmarketing surveillance help to effect optimal drug therapy?B L Strom, K L Melmon
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Drug Therapeutics|January 1, 1982
Post-marketing drug surveillance: an idea whose time has comeB L Strom
Annals of Internal Medicine|August 1, 1990
Pharmacoepidemiology: current status, prospects, and problemsB L Strom, P Tugwell
JAMA|April 20, 2001
Statins and fracture riskS Hennessy, B L Strom
Annals of Internal Medicine|February 26, 2000
Nonsedating antihistamines should be preferred over sedating antihistamines in patients who driveS Hennessy, B L Strom
Journal of Clinical Pharmacology|June 1, 1988
The gastrointestinal side effects of the nonsteroidal anti-inflammatory drugsJ L Carson, B L Strom
Journal of Chronic Diseases|January 1, 1986
Evaluating and monitoring the safety and efficacy of drug therapy and surgeryP D Stolley, B L Strom
Medical Toxicology|July 1, 1986
Techniques of postmarketing surveillance. An overviewJ L Carson, B L Strom
Clinical Pharmacology and Therapeutics|August 1, 1993
A systematic integrated approach to improvement of drug prescribing in an acute care hospital: a potential model for applied hospital pharmacoepidemiologyB L Strom, G A Gibson
American Journal of Respiratory and Critical Care Medicine|February 1, 1995
Inhaled beta-adrenergic receptor agonists in asthma: more harm than good?T E Barrett, B L Strom
JAMA|November 30, 1979
Can postmarketing surveillance help to effect optimal drug therapy?B L Strom, K L Melmon
Pageof 19